PLCG1 and cancer: Within this study, the drug-sensitivity analysis uncovered a negative correlation between the expression levels of the prognostic-related genes (PRGs) utilized in the model (IL18, CASP3, GSDMA, and PLCG1) and the majority of drugs present in the cancer therapeutic response portal database.